A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL reduces the chance that anal cancer will develop by more than half. Results from the Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published in the New England Journal of Medicine. The trial...
Tag: <span>anal cancer</span>
Post
Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV
Groundbreaking National Clinical Trial Halted Due to Therapy’s High Success Rates. Treating precursor anal cancer lesions can significantly reduce the risk of progression to full blown anal cancer among people living with HIV, according to results of a large, phase 3 study led by researchers at UC San Francisco. In a randomized clinical trial with...
Post
The unusual rash that turned out to be a sign of anal cancer
The woman had the strange rash for 11 months before seeing a doctor But then she started experiencing vomiting, diarrhoea and stomach pains Tests revealed cancer – and the rash disappeared during treatment Dermatologists have said the rash is a sign of cancer but is very rare By VANESSA CHALMERS HEALTH REPORTER FOR MAILONLINE PUBLISHED: 09:18 EDT, 12 April 2019 | UPDATED: 09:59 EDT, 12 April 2019 A woman who was concerned...